Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-018715

Director sold 6,698 shares at $6.11 ($40,925)

  • Director acquired 6,820 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HEGGIE THERESA · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-12 Grant or award : show line 1 in the form +6,820 59,550 D
2024-06-14 Sale : show line 2 in the form −6,698 $6.11 $40,925 52,852 D
Open-market sales · 6,698 sh · avg $6.11 · $40,925

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-12 Grant or award : show line 3 in the form Automatic Stock Option Grant +49,933 49,933 D
Loading xslF345X05/form4.xml…